These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 15974885)

  • 1. Aspirin and clopidogrel: a sweeping combination in cardiology.
    Manolis AS; Tzeis S; Andrikopoulos G; Koulouris S; Melita H
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):203-19. PubMed ID: 15974885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined antiplatelet therapy: still a sweeping combination in cardiology.
    Manolis AS; Manolis TA; Papadimitriou P; Koulouris S; Melita H
    Cardiovasc Hematol Agents Med Chem; 2013 Jun; 11(2):136-67. PubMed ID: 23597106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel and risk for acute coronary events.
    Mood GR; Bhatt DL
    Curr Atheroscler Rep; 2007 Nov; 9(5):401-8. PubMed ID: 18001624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of clopidogrel in the management of patients with ischemic heart disease.
    Chopra V; Marmur JD; Cavusoglu E
    Cardiovasc Drugs Ther; 2003; 17(5-6):467-77. PubMed ID: 15107602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
    Hankey GJ; Sudlow CL; Dunbabin DW
    Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
    Savi P; Herbert JM
    Semin Thromb Hemost; 2005 Apr; 31(2):174-83. PubMed ID: 15852221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel: how good is it and how does it work?
    Santa-Cruz RA; Steinhubl SR
    Curr Cardiol Rep; 2004 Jul; 6(4):264-8. PubMed ID: 15182601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopidogrel and aspirin in cardiovascular medicine: responders or not--current best available evidence.
    Tourmousoglou CE; Rokkas CK
    Cardiovasc Hematol Agents Med Chem; 2008 Oct; 6(4):312-22. PubMed ID: 18855644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
    Mehta SR; Yusuf S
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):79S-88S. PubMed ID: 12644345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of clopidogrel.
    Sarafoff N; Byrne RA; Sibbing D
    Curr Pharm Des; 2012; 18(33):5224-39. PubMed ID: 22724411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticlopidine and clopidogrel.
    Quinn MJ; Fitzgerald DJ
    Circulation; 1999 Oct; 100(15):1667-72. PubMed ID: 10517740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy in populations at high risk of atherothrombosis.
    Faxon DP; Nesto RW
    J Natl Med Assoc; 2006 May; 98(5):711-21. PubMed ID: 16749646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.
    Keller TT; Squizzato A; Middeldorp S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005158. PubMed ID: 17636787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The basis of platelets: platelets and atherothrombosis: an understanding of the lack of efficacy of aspirin in peripheral arterial disease (PAD) and diabetic patients].
    Drouet L; Bal dit Sollier C; Henry P
    Drugs; 2010 Nov; 70 Suppl 1():9-14. PubMed ID: 20977287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
    Sudlow CL; Mason G; Maurice JB; Wedderburn CJ; Hankey GJ
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD001246. PubMed ID: 19821273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
    Bhatt DL; Topol EJ;
    Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus.
    Valentine N; Van de Laar FA; van Driel ML
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD005449. PubMed ID: 23152231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thienopyridines.
    Lubbe DF; Berger PB
    J Interv Cardiol; 2002 Feb; 15(1):85-93. PubMed ID: 12053688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel in acute coronary heart disease.
    Din JN; Fox KA
    Am Heart Hosp J; 2005; 3(4):234-42. PubMed ID: 16330915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.